Condition
Malaria Vaccine
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
P 2 (2)
P 4 (1)
Trial Status
Completed2
Recruiting2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05380388Phase 2Not Yet Recruiting
A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )
NCT07416461Recruiting
Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease
NCT07194499Completed
Knowledge and Attitude Among Healthcare Workers Towards Malaria Vaccine, Sudan 2025.
NCT06860178Phase 4RecruitingPrimary
Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa
NCT02992119Phase 2CompletedPrimary
Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults
Showing all 5 trials